Bio-Techne
TECH
333 hedge funds and large institutions have $5.43B invested in Bio-Techne in 2018 Q1 according to their latest regulatory filings, with 64 funds opening new positions, 103 increasing their positions, 110 reducing their positions, and 23 closing their positions.
178% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 23
30% more call options, than puts
Call options by funds: $1.89M | Put options by funds: $1.45M
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
15% more capital invested
Capital invested by funds: $4.72B → $5.43B (+$708M)
12% more funds holding
Funds holding: 297 → 333 (+36)
6% less repeat investments, than reductions
Existing positions increased: 103 | Existing positions reduced: 110
5.27% less ownership
Funds ownership: 388.84% → 383.57% (-5.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$53.1M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$24.8M |
| 3 |
TCM
TimesSquare Capital Management
New York
|
+$23.3M |
| 4 |
SCP
Sandhill Capital Partners
Buffalo,
New York
|
+$21.3M |
| 5 |
DDC
DF Dent & Co
Baltimore,
Maryland
|
+$17.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Select Equity Group
New York
|
-$96.4M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$49M |
| 3 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
-$48.1M |
| 4 |
Goldman Sachs
New York
|
-$12.8M |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
-$10.1M |
TECH Hedge Fund Activity: Q1 2018 in Review
333 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q1 2018, worth a combined $5.43B — up 15% from $4.72B a quarter earlier.
Buyers outnumbered sellers: 64 funds opened new TECH positions and 23 closed out — a net gain of 41 holders — while 103 added to existing stakes and 110 trimmed.
The largest buyer was Massachusetts Financial Services, adding an estimated $53.1M. The largest seller was Select Equity Group, cutting an estimated $96.4M.
- 333 institutional investors held Bio-Techne (TECH) as of Q1 2018, up from 297 in Q4 2017.
- Funds reported $5.43B of Bio-Techne stock for Q1 2018, up 15% quarter-over-quarter.
- 64 funds opened new Bio-Techne positions in Q1 2018 and 23 closed out, a net change of +41 holders.
- The largest Bio-Techne buyer in Q1 2018 was Massachusetts Financial Services, an estimated $53.1M added.
- The largest Bio-Techne seller in Q1 2018 was Select Equity Group, an estimated $96.4M sold.
Based on aggregated 13F filings for Q1 2018.